Oncology News

Among women with stress urinary incontinence and endometrial intraepithelial neoplasia or early-stage cancer, concomitant surgeries for both conditions did not improve quality of life compared with cancer surgery alone, researchers reported.

Among premenopausal women in Korea, family history of breast cancer was positively associated with increased breast density and persistently dense breasts over time, according to findings published in JAMA Network Open.

Multiple models of ChatGPT effectively adhered to screening guidelines by identifying correct imaging services for breast cancer and breast pain, according to researchers.

Having higher cardiorespiratory fitness may be a protective factor against breast cancer for postmenopausal women with elevated body fat, according to the results of research published in the British Journal of Sports Medicine.

Survivors of cancer in adolescence and young adulthood face increased risk for subsequent HPV-related cancer diagnoses, according to research conducted at University of Utah’s Huntsman Cancer Institute.

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.

High allostatic load appeared associated with increased risk for all-cause mortality among patients with breast cancer, according to study results published in JAMA Network Open.

Researchers at The Ohio State University have launched an international clinical trial that will compare minimally invasive robotic surgery with open surgery for women undergoing radical hysterectomy for cervical cancer.

While the percentage of women and nonwhite individuals in academic medicine and biomedical research has increased, the proportion of women among recipients of the Lasker Award has not changed in more than 7 decades.

CHICAGO — First-line use of cyclin-dependent kinase 4/6 inhibitors did not confer significant benefit vs. second-line use when added to endocrine therapy for women with hormone receptor-positive, HER2-negative, advanced breast cancer.